<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">transcription-profiling-of-human-leukemia-cell-l-2</item><item key="factor_count">2</item><item key="sample_count">42</item><item key="tags"><item>cell</item><item>cytokine</item><item>disease</item><item>leukemia</item><item>organ</item><item>peripheral</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-24147</item><item key="id">3808</item><item key="name">Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.</item></item><item><item key="slug">transcription-profiling-of-human-monocyte-derive-7</item><item key="factor_count">0</item><item key="sample_count">6</item><item key="tags"><item>dendritic</item><item>guanine</item><item>left</item><item>leukemia</item><item>macrophage</item><item>monocyte</item><item>nucleotide</item><item>synapse</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-6090</item><item key="id">4816</item><item key="name">Transcription profiling of human monocyte derived dendritic cells treated with DC-SIGN initiates an immature dendritic cell phenotype triggering Rho activation that is utilised by HIV-1</item></item><item><item key="slug">transcription-profiling-of-human-primary-cd34-acut</item><item key="factor_count">1</item><item key="sample_count">24</item><item key="tags"><item>left</item><item>leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-7538</item><item key="id">4915</item><item key="name">Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)</item></item><item><item key="slug">transcription-profiling-of-human-samples-from-the</item><item key="factor_count">0</item><item key="sample_count">204</item><item key="tags"><item>cell</item><item>genome</item><item>leukemia</item><item>line</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-11135</item><item key="id">2846</item><item key="name">Transcription profiling of human samples from the MILE (Microarray Innovations In LEukemia) study pre-phase to investigate cross site reproducibility</item></item><item><item key="slug">transcription-profiling-of-human-t-all-cell-cultur</item><item key="factor_count">0</item><item key="sample_count">28</item><item key="tags"><item>cell</item><item>cell nucleus</item><item>leukemia</item><item>lymphoblastic leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-5827</item><item key="id">4764</item><item key="name">Transcription profiling of human T-ALL cell cultures treated with Compound E, a gamma-secretase inhibitor or vehicle only (DMSO) for 24 h</item></item><item><item key="slug">transcription-profiling-of-human-t-all-cell-lines</item><item key="factor_count">0</item><item key="sample_count">12</item><item key="tags"><item>acute lymphoblastic leukemia</item><item>cell</item><item>leukemia</item><item>line</item><item>lymphoblastic leukemia</item><item>notch</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-18198</item><item key="id">3422</item><item key="name">Transcription profiling of human T-ALL cell lines treated with DMSO or SAHM1</item></item><item><item key="slug">transcription-profiling-of-human-t-all-cog-study-9</item><item key="factor_count">0</item><item key="sample_count">50</item><item key="tags"><item>acute lymphoblastic leukemia</item><item>cell</item><item>leukemia</item><item>lymphoblastic leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-14615</item><item key="id">3157</item><item key="name">Transcription profiling of human T-ALL (COG study 9404)</item></item><item><item key="slug">transcription-profiling-of-human-t-all-patients-wi</item><item key="factor_count">0</item><item key="sample_count">92</item><item key="tags"><item>acute lymphoblastic leukemia</item><item>cell</item><item>gene cluster</item><item>leukemia</item><item>line</item><item>lymphoblastic leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-10609</item><item key="id">2750</item><item key="name">Transcription profiling of human T-ALL patients with molecular cytogenetic abnormalities (i.e. TAL1 (n=24), LMO2 (n=9), HOXA (n=5), HOX11/TLX1 (n=7), and HOX11L2/TLX3 (n=22)) reveals the recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-ALL</item></item><item><item key="slug">transcription-profiling-of-human-u937tplzf-rara-in</item><item key="factor_count">0</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>leukemia</item><item>line</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-18476</item><item key="id">3442</item><item key="name">Transcription profiling of human U937T:PLZF-RARa Inducible Cells</item></item><item><item key="slug">transcription-profiling-of-human-untreated-and-fen</item><item key="factor_count">0</item><item key="sample_count">8</item><item key="tags"><item>cell</item><item>chronic myeloid leukemia</item><item>genome</item><item>leukemia</item><item>line</item><item>myeloid leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-17480</item><item key="id">3375</item><item key="name">Transcription profiling of human untreated and fenretinide-treated CD34+ cells from 4 CML patients</item></item></data></biogps>
